Compare WAVE & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WAVE | JSPR |
|---|---|---|
| Founded | 2011 | 2018 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.3M | 48.1M |
| IPO Year | 2021 | N/A |
| Metric | WAVE | JSPR |
|---|---|---|
| Price | $6.13 | $1.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 11 |
| Target Price | $15.00 | ★ $21.44 |
| AVG Volume (30 Days) | 11.4K | ★ 649.1K |
| Earning Date | 11-12-2025 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $168,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $400.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.41 | $1.39 |
| 52 Week High | $11.46 | $21.27 |
| Indicator | WAVE | JSPR |
|---|---|---|
| Relative Strength Index (RSI) | 42.23 | 41.24 |
| Support Level | $5.77 | $1.73 |
| Resistance Level | $6.30 | $2.07 |
| Average True Range (ATR) | 0.32 | 0.14 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 54.33 | 20.91 |
Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.